tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GYRE Stock Latest News

Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
Company AnnouncementsGyre Therapeutics Seeks Compliance Amid Board Reshuffle
17d ago
8K
GYRE
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
PremiumPress Releases
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
20d ago
GYRE
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
PremiumThe Fly
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
20d ago
GYRE
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
PremiumPress Releases
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
1M ago
GYRE
Gyre announces publication in Journal of Gastroenterology and Hepatology
PremiumThe Fly
Gyre announces publication in Journal of Gastroenterology and Hepatology
1M ago
GYRE
Gyre Therapeutics Advances with F230 IND Approval in China
PremiumCompany AnnouncementsGyre Therapeutics Advances with F230 IND Approval in China
2M ago
8K
GYRE
Gyre Therapeutics gets IND okay from China’s NMPA to evaluate F230 for PAH
PremiumThe Fly
Gyre Therapeutics gets IND okay from China’s NMPA to evaluate F230 for PAH
2M ago
GYRE
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
PremiumPress Releases
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
2M ago
GYRE
Gyre Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Gyre Therapeutics files $150M mixed securities shelf
2M ago
GYRE
Gyre Therapeutics files to sell 1.08M shares of common stock for holders
PremiumThe Fly
Gyre Therapeutics files to sell 1.08M shares of common stock for holders
2M ago
GYRE
Catalyst Biosciences Inc trading resumes
PremiumThe Fly
Catalyst Biosciences Inc trading resumes
2M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
2M ago
GYRE
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
PremiumPress ReleasesGyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
2M ago
GYRE
Gyre announces addition to Russell 2000 and 3000 Indexes
PremiumThe Fly
Gyre announces addition to Russell 2000 and 3000 Indexes
2M ago
GYRE
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
GYRE
Gyre Therapeutics Expands Pulmonary Fibrosis Portfolio
PremiumCompany Announcements
Gyre Therapeutics Expands Pulmonary Fibrosis Portfolio
3M ago
8K
GYRE
Gyre Therapeutics Welcomes New Expertise to Board Team
PremiumCompany Announcements
Gyre Therapeutics Welcomes New Expertise to Board Team
4M ago
8K
GYRE
Gyre Therapeutics expands board of directors with appointment of Nussbaum
PremiumThe Fly
Gyre Therapeutics expands board of directors with appointment of Nussbaum
4M ago
GYRE
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
PremiumPress Releases
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
4M ago
GYRE
Gyre Therapeutics: Annual Financial Results and Future Outlook
PremiumCompany AnnouncementsGyre Therapeutics: Annual Financial Results and Future Outlook
5M ago
8K
GYRE
Gyre Therapeutics presents poster on hydronidone at AASLD Meeting
PremiumThe Fly
Gyre Therapeutics presents poster on hydronidone at AASLD Meeting
8M ago
GYRE
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
PremiumPress Releases
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
8M ago
GYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >